Which business models does Aravind Eye Care System use?
Part IThe Story
Eleven Beds in Madurai
In 1976 an ophthalmologist named Govindappa Venkataswamy reached the mandatory retirement age of 58 and left his post as head of ophthalmology at the government medical college in Madurai, a temple city in the south Indian state of Tamil Nadu. Most men in his position would have opened a comfortable private practice. Venkataswamy, whom everyone called Dr. V, instead opened an 11-bed hospital. Six of the beds were for patients who could not pay anything. The other five were for patients who could pay a modest fee. To fund the building, he and his siblings mortgaged their houses, pooled their savings and pawned family jewellery, as Tina Rosenberg later reported in The New York Times.
The hospital was named Aravind, a south Indian rendering of Aurobindo, after the philosopher and mystic Sri Aurobindo, whose teachings Dr. V followed for most of his adult life. Its stated purpose was almost comically large for an 11-bed building: to eliminate needless blindness. India had millions of people who were blind from cataracts, a clouding of the eye's natural lens that a short operation can reverse. The obstacle was never medical knowledge. It was the cost, reach and throughput of the system that had to deliver the operation to people who were poor, rural and often unaware that their blindness could be cured.
Half a century later, the Aravind Eye Care System reports that it handled 6,099,899 outpatient visits and performed 734,322 surgeries, laser procedures and injections in the year to March 2025. Since 1976 it has recorded more than 90 million outpatient visits and more than 10.8 million surgeries. It operates 15 eye hospitals, 8 outpatient examination centres and 118 primary eye care facilities across south India, plus a manufacturing company, a management training institute, a research foundation and eye banks. By its own description it is the largest eye care provider in the world. It has done this while giving roughly half of its care away for free or at steeply subsidised rates, and while financing its growth mainly from its own surpluses.
That combination — enormous charity at enormous scale, paid for by the organisation's own operations — is why Aravind has been taught at Harvard Business School since 1993, why it won the Gates Award for Global Health in 2008 and the Conrad N. Hilton Humanitarian Prize in 2010, and why management writers keep returning to it. It is one of the clearest demonstrations anywhere that a mission-driven organisation can use industrial operations discipline as the engine of its mission rather than as a threat to it.
By the Numbers
The Aravind Eye Care System
6.1MOutpatient visits, year to March 2025
734,322Surgeries, lasers and injections, FY2024-25
10.8M+Surgeries since 1976
~50%Patients treated free or steeply subsidised
15Eye hospitals in the network
118Primary eye care facilities
1976Founded in Madurai with 11 beds
The Doctor With Twisted Hands
Venkataswamy was born on 1 October 1918 in Vadamalapuram, a farming village in what is now Thoothukudi district. There were no doctors in the village. According to Pavithra Mehta and Suchitra Shenoy's history Infinite Vision (2011), he lost cousins to complications of pregnancy when he was a boy, and that experience pushed him toward medicine. He took a chemistry degree from the American College in Madurai in 1938 and a medical degree from Stanley Medical College in Madras in 1944, then served as a physician in the Indian Army.
His intended specialty was obstetrics. In the late 1940s, around the age of 30, he developed a severe form of rheumatoid arthritis that left him bedridden for long stretches and permanently deformed his fingers. Obstetrics was no longer possible. He retrained in ophthalmology, qualifying in 1951, and taught himself to operate with hands that could barely grip. Over his career he personally performed more than 100,000 eye operations, according to the American Society of Cataract and Refractive Surgery.
In 1956 he became head of ophthalmology at Madurai Medical College and eye surgeon at the Government Erskine Hospital. He held those posts for two decades, and the government years shaped the Aravind model more than is often acknowledged. He helped pioneer mobile eye camps that took screening and surgery out to villages, set up a rehabilitation centre for the blind in 1966 and a training programme for ophthalmic assistants in 1973, and received the Padma Shri, one of India's civilian honours, in 1973. Through Sir John Wilson, the founder of the Royal Commonwealth Society for the Blind (now Sightsavers), he became involved in the national effort that led to India's National Programme for Control of Blindness, launched in 1976 with the goal of cutting blindness prevalence from 1.4% to 0.3%.
By the time he retired, then, Dr. V knew three things from experience. He knew that the surgical procedure was cheap and reliable. He knew that the poor would come if the service was brought close enough and made free. And he knew that the government system, however well intended, could not produce the volume the problem required.
— Govindappa Venkataswamy, PBS Religion & Ethics NewsWeekly (interview recorded 1988)There is nothing which disables a man more than cataract and poor eyesight, and there is nothing more easier than to mend it. You just do a small operation.
A Family Firm With a Mission Statement
Aravind began as a family enterprise in the most literal sense. Dr. V founded it with his four siblings and their spouses, and together they formed the GOVEL Trust to own and run the hospital. His sister Dr. G. Natchiar and her husband Dr. P. Namperumalsamy, both ophthalmologists, were central from the start. Namperumalsamy, who had trained under Dr. V and done fellowships in diabetic retinopathy and vitreous surgery in the United States, quit his government post as an assistant professor at Madurai Medical College in 1977 to join full time, a move that Forbes India later described as giving Dr. V the confidence to expand.
The early years were lean. PBS reported that Natchiar and her husband worked for about $20 a month. Natchiar told the programme that the family was not happy in the 1980s, even though her brother was, because the couple, raising two children, could not afford a bicycle. Dr. V never married and never drew a salary, and over time he drew dozens of relatives into the work; PBS counted 34 extended family members on staff in 2009, and The New York Times reported in 2013 that he had at least 21 relatives who were eye surgeons.
The family structure mattered for more than sentiment. It supplied the organisation with a senior team who shared the founder's values without needing to be persuaded, who would accept low pay for years, and who could be trusted with money in a sector where leakage and informal payments were common. It also created a succession path. When Dr. V died on 7 July 2006, at 87, the organisation was already being run by the second generation, including Namperumalsamy, who served as chairman and was named to Time magazine's list of the 100 most influential people in 2010, and Dr. V's nephew Dr. S. Aravind, a surgeon with an MBA from the University of Michigan.
The founding mission, as the Trust defined it, has not changed: to eliminate needless blindness by providing high-quality, compassionate eye care that is affordable for all. The phrasing is worth noticing. It does not say free care, or care for the poor. It says care affordable for all, which leaves room for the paying patient on whom the entire model depends.
👁️
From Eleven Beds to a System
Key milestones in Aravind's history
1976
Dr. V retires from government service and opens an 11-bed hospital in Madurai under the GOVEL Trust.
1977
Dr. P. Namperumalsamy leaves Madurai Medical College to join Aravind full time.
1985
Aravind opens a hospital in Theni, its first outside Madurai.
1988
A hospital opens in Tirunelveli.
1992
Aurolab begins manufacturing intraocular lenses; LAICO, the training and consulting institute, is established.
1993
Harvard Business School publishes its case study on Aravind, In Service for Sight.
1997
Aravind opens in Coimbatore.
2006
Dr. V dies in Madurai on 7 July, aged 87.
2008
Aravind receives the $1 million Gates Award for Global Health.
2010
Aravind receives the $1.5 million Conrad N. Hilton Humanitarian Prize.
2017
Aravind-Chennai opens to mark the centenary of Dr. V's birth.
2019
Aravind opens in Tirupati, its first hospital in Andhra Pradesh.
What a Surgeon Learned From Hamburgers
The best-known detail of the Aravind story is that its founder admired McDonald's. It sounds like a management-book flourish, but it is well documented. In a 1988 interview later broadcast by PBS, Dr. V pointed to American chains as the model he was trying to reproduce: organisations that could open store after store and run each one efficiently. The New York Times reported that he spent a few days at McDonald's Hamburger University in Oak Brook, Illinois.
What he took from fast food was a set of operating disciplines rather than a menu: standardisation, a strict division of labour, obsessive attention to process, consistent quality from outlet to outlet, and above all volume. Rosenberg summarised the result in the Times by saying that Aravind could practise compassion successfully precisely because it ran with assembly-line efficiency, strict quality norms, ruthless cost control and volume.
The curiosity behind this was personal and lifelong. Dr. S. Aravind told the Times that his uncle would walk around an airport with the janitor to see how the toilets were cleaned, and follow the catering staff around a five-star hotel. The point was not hygiene or hospitality as such. Dr. V was looking for any system, in any industry, that turned a repeated task into a reliable process, because the problem he had chosen to solve was a repeated task performed millions of times.
— Govindappa Venkataswamy, PBS Religion & Ethics NewsWeekly (1988 interview)In America you have models, whether it is Sears stores or McDonald's hamburgers. You are able to open a chain of stores, restaurants, hotels, and you are able to organize them efficiently.
The Operating Theatre as a Production Line
The clearest expression of that thinking is Aravind's operating theatre. Forbes India described a typical morning at the Madurai hospital in 2016: each theatre had four tables worked by two surgeons, with a large microscope positioned between each surgeon's pair of tables. While the surgeon removes a clouded lens and implants an artificial one on the first table, trained assistants are preparing the next patient on the second. When the surgeon finishes, the microscope swings across and the assistants take over the bandaging and move the first patient out. A third patient is already waiting. The rhythm continues until mid-afternoon.
The effect on productivity is dramatic. Forbes India reported that an Aravind surgeon spends 5 to 10 minutes per patient, averages about 50 operations a day and performs at least 2,000 a year, compared with 300 to 400 for surgeons elsewhere in India and around 200 in developed countries. The New York Times gave similar figures. The operation itself is identical to the one performed elsewhere. What differs is that the surgeon does only the part of the job that requires a surgeon.
The rest is done by what Aravind calls mid-level ophthalmic personnel, or MLOPs. These are mostly young women recruited from surrounding villages after secondary school and trained by Aravind in narrowly defined roles: registration, refraction, counselling, pre-operative preparation, theatre assistance, nursing. Forbes India counted 2,800 of them in 2016. They are the reason the model scales despite India's shortage of ophthalmologists, and they are also a large part of why the cost structure works, since they are paid far less than doctors and take on most of the patient-facing hours.
The discipline reaches outpatient care too. When PBS visited in 2009, Dr. S. Aravind showed the reporter a clinic scoring sheet that tracked what percentage of patients were seen within two hours, the service time the hospital promised. A brochure told patients how long each step should take: about five minutes for registration, ten for the vision test, ten for refraction. The patient, in effect, was handed a service-level agreement.
Speed has not come at the expense of outcomes. Rosenberg reported in 2013 that Aravind's rate of surgical complications was half that of eye hospitals in Britain, and that the system performed about 60% as many eye surgeries as Britain's National Health Service at one-thousandth of the cost. Aravind's own view, repeated in its reports, is that volume improves quality: surgeons who perform thousands of operations a year get very good at them and see the rare complications often enough to manage them well.
Letting Patients Choose What They Pay
If the operating theatre is the engine, the pricing system is the fuel. Aravind runs what are, in effect, two hospitals side by side: a paying section and a free section. There is no means test. Patients decide for themselves which door to walk through. Those who pay choose among several levels of accommodation and lens type; Forbes India reported eight price points in 2016. Those who do not pay receive the same surgeons and the same surgical standard, with simpler lodging. The New York Times described free patients sleeping on mats in 30-person dormitories while paying patients could opt for private, air-conditioned rooms. The doctors rotate between the two sides.
The paying patients fund everything else. In the year to March 2025, Aravind's activity report shows 370,500 surgeries, lasers and injections in paying sections, 257,052 for subsidised walk-in patients at the free hospitals, and 106,770 free procedures for patients brought in through screening camps. Put differently, only about half of the procedures in the year generated a full fee.
The model has produced healthy surpluses. Forbes India reported that in 2014-15 Aravind's income was Rs 233.74 crore against expenses of Rs 162.98 crore, a surplus of Rs 70.76 crore, and that it was a zero-debt organisation that did not seek donations for its core operations. That year, according to Namperumalsamy, 22% of its 408,000 surgeries were free, 28% heavily subsidised and 50% charged in full. Infinite Vision reported an operating surplus of roughly $13 million on revenue of about $29 million in 2009-10.
Two features make this unusual among charities. First, the subsidy is internal. Aravind does accept grants for specific projects, and it has partners such as Lions Clubs International and the Seva Foundation, but the day-to-day free care is paid for by other patients, not by donors. Second, the paying patients are not being overcharged to fund charity. Rosenberg reported that they still paid far less than they would at other Indian hospitals. Aravind's efficiency is what lets a modest fee cover more than its own cost.
Going Out to Find the Blind
A hospital that depends on volume cannot wait for patients to arrive. Most people blind from cataracts in rural India, as Rosenberg noted, do not know why they are blind or that a short operation can restore their sight. Aravind has therefore always spent heavily on finding them.
The first tool was the eye camp, carried over from Dr. V's government years. Teams of doctors and staff travel to villages, often in partnership with local sponsors who pay for the camp, screen hundreds of people in a day, dispense glasses on the spot and bring patients who need surgery back to an Aravind hospital, with transport, food, lodging and a follow-up visit provided free. Forbes India reported more than 2,500 camps a year across Tamil Nadu and Puducherry. In 2024-25, camps accounted for 563,822 outpatient visits.
Camps have a structural weakness, and Aravind measured it. When it surveyed the villages it served, it found that the camps were reaching only about 7% of the people who needed care, largely because they came around infrequently, according to the Times. The response was the vision centre: a small permanent storefront clinic in a rural town, staffed by Aravind-trained technicians and connected by video to doctors at a base hospital. Forbes India reported that such a centre cost about Rs 5 lakh to set up. Namperumalsamy, who drove the programme, told the magazine that Aravind had previously held camps at its own convenience rather than the patient's. Rosenberg reported that vision centres raised Aravind's penetration in their areas to around 30% within a year of opening.
By March 2025 Aravind was running 117 vision centres, which handled 1,019,806 patient visits in the year, more than the screening camps. The funnel that feeds the operating theatres now starts in hundreds of small rooms scattered across the countryside.
Aurolab and the Price of a Lens
The most consequential strategic decision in Aravind's history came in response to a change in surgical technique. In the 1980s, cataract surgery with an implanted intraocular lens (IOL) became the international standard. The older procedure, which removed the clouded lens and relied on thick spectacles afterward, gave far poorer vision. But the new lenses were imported and expensive. According to The New York Times, Aravind could persuade manufacturers to cut the price only from about $100 to $70 per lens.
That created a problem that went to the heart of the organisation's values. Offering lens implants only to paying patients would create two classes of surgery, which the founders refused to accept. Charging paying patients enough to cover lenses for everyone would break the pricing model. Aravind's answer was to make the lenses itself.
Aravind set up Aurolab in Madurai in 1992. Its lenses were sold at a small fraction of prevailing prices; PBS reported in 2009 that some cost as little as $2 to make, compared with $50 to $100 for imported lenses in the past, and that Aurolab held about 8% of the global IOL market. Aurolab went on to make sutures, surgical blades, pharmaceuticals and equipment, and Forbes India reported in 2016 that it exported to 146 countries. Its effect reached beyond Aravind: Rosenberg noted that it helped force down the price of lenses from other manufacturers as well.
Aurolab is the move that turned a clever hospital into a system. It removed the single largest variable cost in cataract surgery, protected the principle that every patient gets the same operation, gave Aravind a second source of income, and extended the organisation's influence into every hospital in the developing world that bought its lenses.
Giving the Recipe Away
In 1992, the same year Aurolab started production, Aravind established the Lions Aravind Institute of Community Ophthalmology, known as LAICO, with support from Lions Clubs International. LAICO is Aravind's training and consulting arm. It teaches hospital management, outreach, instrument maintenance and eye bank management, and it sends Aravind staff to help other hospitals redesign their operations. According to LAICO, it has worked with more than 400 hospitals in India and other developing countries and trained more than 3,500 professionals from more than 80 countries, and it estimates conservatively that its work has produced about a million additional surgeries a year.
Aravind is unusually open about its methods. R.D. Thulasiraj, the long-serving head of LAICO and later director of operations, told PBS in 2009 that the institution opens its systems, processes, patient charging and records to other organisations. Aravind has no competitive reason to hide them. Its mission is measured in blindness eliminated, not market share, and every other hospital that becomes more productive advances the mission.
Replication has been uneven, which says something about what is and is not transferable. Dr. S. Aravind told the Times in 2013 that of roughly 300 hospitals using the model, about 20% absorbed the whole thing, about half adopted pieces such as more efficient operating-table layouts, and the rest struggled. The McDonald's part, he suggested, is the easiest to export. The commitment to serving as many free patients as possible is harder.
— R.D. Thulasiraj, PBS Religion & Ethics NewsWeekly (2009)In this institution we train organizations to become more efficient. We completely give our intellectual property or our store away. We open up our systems, processes, how we charge the patients, our records.
Beyond the Cataract Factory
Success at cataract surgery brought a reputational risk: being seen as nothing more than a cataract factory. Thulasiraj credited Namperumalsamy, in the Forbes India profile, with changing that perception. A retina specialist himself, Namperumalsamy pushed Aravind into diabetic retinopathy, vitreoretinal surgery, glaucoma and research. By 2016, Forbes India reported, only 61% of Aravind's surgeries were for cataract.
The shift reflects a change in India's disease burden. As diabetes has spread, diabetic retinopathy has become a major cause of blindness that, unlike cataract, cannot be reversed once vision is lost. It can only be prevented through regular screening and timely laser treatment or injections. Aravind's 2024-25 activity report shows how far the mix has moved: alongside 450,901 cataract operations, the system performed 72,391 retinal laser procedures and 50,598 intravitreal injections during the year.
Aravind has also become one of India's main training institutions for ophthalmologists. Its postgraduate institute runs residency and fellowship programmes across the sub-specialties, and its research arm, the Aravind Medical Research Foundation, works on problems such as corneal ulcers and the genetics of eye disease. In 2024 it opened ARCORE, a training facility at Aravind-Chennai, with industry partners including Alcon, Zeiss and Essilor.
Geographic growth has continued at a measured pace. After Theni, Tirunelveli and Coimbatore came hospitals in Puducherry, Salem, Tirupur, Dindigul, Udumalpet and other towns, a large hospital in Chennai in 2017 marking Dr. V's centenary, and Tirupati in Andhra Pradesh in 2019. Aravind has also managed partner hospitals elsewhere in India under agreements with local trusts and companies.
The Legacy Problem
Every founder-led organisation eventually faces the question of whether it can outlive the founder's personal example. For Aravind the question was sharper than usual, because Dr. V's authority rested on his asceticism and spiritual conviction as much as on his skill. He took no salary, lived with his brother's family and spoke about the work in the language of Sri Aurobindo, as an instrument of a higher consciousness.
Aravind's answer has been to institutionalise the values while keeping the family at the centre. Thulasiraj told Forbes India that Dr. V spread the values on a personal level while Namperumalsamy institutionalised them. Dr. R.D. Ravindran later became chairman, with Namperumalsamy and Natchiar as chairman and vice-chairman emeritus. The third generation of the extended family now works across the hospitals.
The risks are real. A family-dominated leadership can become closed to outside talent. The model depends on a continuing supply of surgeons willing to accept Aravind's pay and pace, and of village recruits willing to train as MLOPs as India's economy offers young women more alternatives. And the organisation's core economics depend on paying patients choosing Aravind in a market where for-profit eye hospital chains have expanded quickly.
Dr. S. Aravind put the cultural risk plainly in 2013: community outreach, he told the Times, is the easiest part to sacrifice, because it can always be justified as something to return to once the organisation is bigger. The staff, he said, watch how leaders prioritise between paying and free patients. Aravind's claim to its founder's legacy rests on continuing to make that choice in favour of the free patient.
— Dr. S. Aravind, The New York Times (2013)Never restrict demand. Build your capacity to meet the demand.
Part IIThe Playbook
Aravind is often cited as a feel-good story about compassionate medicine. It is better read as a masterclass in operations strategy, one in which every major design choice serves a single measurable mission. The principles below are drawn from the specific decisions that let an 11-bed hospital become the world's largest eye care provider without depending on donors.
The principles
- 1.Pick a problem that rewards volume.
- 2.Let the scarce expert do only the expert part.
- 3.Let customers choose their own price.
- 4.Give everyone the same core product.
- 5.Go out and create your own demand.
- 6.Make the input that is holding you hostage.
- 7.Borrow operating systems from other industries.
- 8.Fund growth from surplus, not debt.
- 9.Give the playbook away.
- 10.Make the free customer the design constraint.
Principle 1
Pick a problem that rewards volume.
Aravind's model works because cataract surgery has an unusual set of properties. It is a short, standardised procedure with a very high success rate. It cures the condition permanently. And, as the Berkeley engineer Jaspal Sandhu pointed out to The New York Times, cataracts do not discriminate much by income, so the same procedure serves the rich and the poor. That means one production line can serve both the patients who pay and the patients who do not.
Those properties made economies of scale available on a scale few medical specialties allow. Buildings, equipment and surgeons are fixed costs; every additional operation spreads them thinner. Aravind's cost per surgery falls as volume rises, and its quality rises too, because surgeons who perform 2,000 operations a year become extremely good at them.
Benefit: A volume-friendly problem lets the organisation lower unit cost and improve quality at the same time, which is what makes cross-subsidy affordable.
Tradeoff: The model is hard to transplant into specialties with long, variable, chronic treatment. Aravind's own move into retina and glaucoma care requires more ongoing follow-up and less of the one-visit throughput that made cataract surgery so efficient.
Tactic for operators: Before designing an operating model, ask whether your core unit of work is repeatable, standardisable and demanded across customer segments. If it is, build for volume first and let price follow.
Principle 2
Let the scarce expert do only the expert part.
India has never had enough ophthalmologists. Aravind responded by redesigning the job so that surgeons spend almost all their time on the few minutes that require a surgeon: removing the clouded lens and implanting the new one. Everything else — registration, testing, counselling, preparation, bandaging — is handed to trained mid-level staff. The four-table, two-surgeon theatre that Forbes India described is the physical expression of that idea.
This is specialization applied to a bottleneck. The surgeon is the constraint on the whole system's output, so every minute the surgeon spends waiting or doing non-surgical work is capacity lost for good. Aravind's MLOPs, 2,800 of them in 2016, are the reason one surgeon can do the work of five or six elsewhere.
Benefit: Output rises several-fold without adding scarce, expensive experts, and the experts get more practice at the work that matters most.
Tradeoff: The model depends on a steady supply of trainable support staff and on a surgical culture that accepts a narrow, repetitive role. It can also create fatigue and burnout if volume targets are pushed too hard.
Tactic for operators: Map where your most expensive people spend their time. Strip out every task that someone with narrower training could do reliably, and redesign the workflow so the expert is never idle.
Principle 3
Let customers choose their own price.
Aravind does not means-test its patients. It offers a menu, from free care with a mat in a dormitory to paid care with private air-conditioned rooms and premium lenses, and lets each patient decide. This is price discrimination by self-selection. The differences between the tiers lie in comfort and in the lens options, not in the surgeon or the surgical standard, so patients who can pay have reason to do so, and patients who cannot are never turned away.
Self-selection is cheaper and more humane than verification. There are no income checks to administer, no documents to forge, no stigma attached to a caseworker's judgement. Forbes India reported that half of Aravind's surgeries in 2014-15 were charged in full, and those fees supported the rest.
Benefit: Self-selected tiers capture more of what better-off customers are willing to pay while keeping the door open to everyone, without the overhead of eligibility checks.
Tradeoff: The system depends on enough patients choosing to pay. If paying patients drift to competitors offering more comfort or prestige, the subsidy shrinks.
Tactic for operators: When customers differ widely in willingness to pay, design tiers that differ in amenities rather than in core quality, and let customers sort themselves.
Principle 4
Give everyone the same core product.
Aravind's founders refused to offer a second-class operation to the poor. That refusal is why Aurolab exists, and it is also why surgeons rotate between the paying and free wings. The same doctors operating on both groups is a quality-control mechanism: nobody can quietly lower standards on the free side without lowering their own.
The equal-care rule also protects the brand. Paying patients trust Aravind partly because it is the place everyone in the region goes for eye surgery, and in 2009 PBS met a patient who had endured a two-day train journey to reach Madurai because of that reputation. A two-tier quality system would have eroded the brand on which the paying volume depends.
Benefit: A single quality standard protects outcomes for the most vulnerable customers, keeps staff culture coherent and builds the reputation that attracts paying customers.
Tradeoff: It limits how cheaply the free service can be delivered, and it forces expensive decisions such as building a lens factory, rather than accepting a cheaper inferior option.
Tactic for operators: Draw a hard line around the core product that every customer receives, and let pricing tiers vary only outside it. Enforce the line by having the same people deliver it to every tier.
Principle 5
Go out and create your own demand.
Most hospitals wait for patients. Aravind recruits them. Its eye camps and vision centres are, in commercial terms, a customer-acquisition machine that feeds the operating theatres. The camps bring in patients who would never have made the journey alone. The vision centres, created after Aravind measured how few people the camps were reaching, give the system a permanent presence in rural towns.
The approach follows directly from Dr. S. Aravind's rule, reported by the Times, never to restrict demand but to build capacity to meet it. A volume model that stops seeking demand stalls; a volume model that seeks demand aggressively keeps its unit costs falling.
Benefit: Active outreach fills capacity, keeps unit costs low and reaches the customers who most need the service and are least likely to find it on their own.
Tradeoff: Outreach is expensive, and it is the first cost that comes under pressure when budgets tighten, as Dr. S. Aravind warned. It also brings in the patients who pay least.
Tactic for operators: Measure your penetration of the people who need your product, not just your sales. If it is low, invest in permanent, local points of access rather than occasional campaigns.
Principle 6
Make the input that is holding you hostage.
When implanted lenses became the standard of care, Aravind's biggest cost was controlled by overseas manufacturers who would cut prices only so far. Aravind's response was to start making lenses. Aurolab, founded in 1992, brought the price of an intraocular lens down to a few dollars and eventually supplied hospitals in well over a hundred countries.
The decision reflects a clear view of core competency. Aravind was not a manufacturer, but it understood the product intimately, consumed it in huge volume and had a partner network that helped it acquire the technology. Vertical integration here removed a single point of failure in the business model and turned a cost into a revenue stream.
Benefit: Controlling a critical input removes supplier leverage, lowers costs across the system and can create a new business that serves the wider market.
Tradeoff: Manufacturing brings capital requirements, regulatory obligations and a different kind of management challenge. It only makes sense when the input is critical and the organisation is a large enough buyer to run a factory efficiently.
Tactic for operators: Identify the input whose price or availability most constrains your model. If you are a large buyer and the supplier market is concentrated, test whether making it yourself is feasible.
Principle 7
Borrow operating systems from other industries.
Dr. V's inspiration came from McDonald's and Sears, not from other hospitals. He studied how chains standardised their work, how airport janitors cleaned, how hotel caterers ran their kitchens. The resulting system — written service-time targets, standard workflows, clinic scoring sheets, assembly-line theatres — imported standard operating procedures from retail and manufacturing into a field that had treated each operation as a craft.
The lesson is that the best operating ideas often come from the least obvious industries, because the constraint they solve for — consistency at scale — is the same.
Benefit: Cross-industry borrowing brings proven solutions into fields where they are rare, giving an early adopter a large and lasting productivity advantage.
Tradeoff: Methods from one field need translation. Industrial metaphors can alienate professionals, and the "factory" label became a reputational problem Aravind later had to work against.
Tactic for operators: When you are stuck on an operational problem, find the industry that has solved the equivalent problem at the greatest scale and study it in person.
Principle 8
Fund growth from surplus, not debt.
Aravind was started with mortgaged homes and pawned jewellery, and it has grown mainly on its own surpluses. Forbes India described it in 2016 as zero-debt and not seeking donations for its core operations. That financial independence has a strategic function: it means nobody outside the organisation can insist that it charge more, serve fewer free patients or slow its outreach.
Benefit: Self-funding preserves control over the mission and forces discipline on costs, since there is no outside money to cover waste.
Tradeoff: Growth is slower than it could be with borrowed capital, and the organisation carries the full risk of any downturn in paying volume.
Tactic for operators: If your mission depends on decisions that outside capital would challenge, design the business to throw off enough surplus to fund its own growth, even if that means expanding more slowly.
Principle 9
Give the playbook away.
Through LAICO, Aravind has trained thousands of managers and worked with hundreds of hospitals, openly sharing its systems, prices and records. For a commercial company that would be reckless. For Aravind it is rational: its goal is measured in blindness prevented worldwide, and every hospital that copies its methods advances that goal. LAICO estimates its work adds about a million surgeries a year elsewhere.
Openness also brings indirect returns. It spreads the Aravind name, attracts trainees and partners, creates buyers for Aurolab products and draws in the international awards and grants that fund specific projects.
Benefit: When the mission is larger than the organisation, sharing methods multiplies impact far beyond what the organisation could achieve alone, while building reputation and partnerships.
Tradeoff: Most imitators capture only part of the model. Dr. S. Aravind estimated that only about a fifth of the hospitals using it absorbed the whole system.
Tactic for operators: Separate what you must protect from what you can share. If your advantage lies in culture and execution rather than in secrets, teaching your methods openly can build influence without eroding your position.
Principle 10
Make the free customer the design constraint.
The most distinctive thing about Aravind is that the free patient shapes the whole system. Because the free patient must receive the same surgery, Aravind built a lens factory. Because the free patient cannot pay for travel, Aravind built camps and vision centres. Because a large share of patients pay little or nothing, Dr. S. Aravind told the Times, the whole cost structure is tuned to that reality. The paying patient benefits from the efficiency that the free patient forced.
Benefit: Designing for the hardest customer produces a cost structure and a service so efficient that it becomes a competitive advantage with everyone else.
Tradeoff: It requires leadership willing to forgo easier revenue, and the discipline erodes quickly if leaders begin to prioritise paying customers.
Tactic for operators: Identify the customer who can pay the least and still needs your full product. Design your cost structure so you can serve that customer sustainably, and the rest of the market will follow.
Conclusion
Compassion as an Operating System
Aravind's playbook can be summarised as a set of choices, each serving a single measurable mission. It chose a problem that rewards volume. It redesigned work around its scarcest resource. It let patients price themselves and gave them all the same surgery. It went looking for demand, made its own critical input, borrowed its methods from fast food and funded itself. Then it gave the recipe away.
None of those ideas is unique on its own. What makes Aravind rare is that they reinforce each other, and that they have been held together for 50 years by a culture that treats the free patient as the reason the organisation exists. The operating system can be taught. The priority it serves is what makes it work.
Free playbook
Get The Business Model Playbook
58 business models, one visual page each: how the money flows, the metrics that matter, and who runs it. Free when you join the Faster Than Normal email.
Free. No spam. Unsubscribe anytime.
Part IIIBusiness Breakdown
The Business at a Glance
Vital Signs
Aravind Eye Care System — FY2024-25
6,099,899Outpatient visits
734,322Surgeries, lasers and injections
450,901Cataract surgeries
370,500Procedures in paying sections
363,822Subsidised or free procedures
117Vision centres
Rs 70.76 crSurplus in 2014-15 (Forbes India)
The Aravind Eye Care System is a network of charitable eye hospitals and related institutions managed by the GOVEL Trust and headquartered in Madurai. By its own description it is the largest eye care provider in the world. Its facilities include 15 eye hospitals, 8 outpatient examination centres and 118 primary eye care facilities in south India, alongside the Aravind Postgraduate Institute of Ophthalmology, LAICO, Aurolab, the Aravind Medical Research Foundation and several eye banks.
Aravind does not publish consolidated financial statements in the manner of a listed company. The most detailed public figures come from media reports and case studies: Forbes India reported income of Rs 233.74 crore and a surplus of Rs 70.76 crore in 2014-15, while Infinite Vision cited an operating surplus of about $13 million on revenue of about $29 million in 2009-10.
How Aravind Makes Money
Aravind's income comes overwhelmingly from patient fees in its paying sections, supplemented by income from its affiliated institutions and by grants for specific programmes. The free sections and outreach are funded by the surplus from paying patients.
💰
Where the Volume Comes From
Aravind patient activity, April 2024 to March 2025
| Channel | Outpatient visits | Surgeries, lasers and injections |
|---|---|---|
| Paying sections | 3,123,566 | 370,500 |
| Free sections (walk-in, subsidised) | 1,170,203 | 257,052 |
| Screening camps | 563,822 | 106,770 (free) |
| Vision centres | 1,019,806 | Referred to base hospitals |
| Community eye clinics and city centres | 222,502 | Referred to base hospitals |
| Total | 6,099,899 | 734,322 |
Pricing: Patients choose their own tier, with no means test. Forbes India reported eight price points across paying and subsidised care in 2016. PBS reported in 2009 that a consultation in the paying section cost about a dollar. Paying tiers differ in accommodation and lens choice; the surgeons and surgical standards are the same across tiers.
Unit economics: Aravind's cost advantage comes from surgeon productivity (at least 2,000 operations per surgeon per year, against 300 to 400 elsewhere in India, per Forbes India), from the heavy use of trained mid-level staff, and from in-house supply of lenses and consumables through Aurolab. High volume spreads the fixed cost of buildings, equipment and specialists across many more patients.
Affiliated income: Aurolab sells lenses, sutures, pharmaceuticals and equipment in India and abroad. LAICO charges for training and consulting. Aravind also runs a postgraduate institute that trains ophthalmologists and support staff.
Competitive Position and Moat
Aravind operates in a crowded field. India's government runs its own blindness control programme, dating from 1976. Charitable eye hospitals such as Sankara Nethralaya in Chennai (founded 1978) and the L V Prasad Eye Institute in Hyderabad (founded 1987) are major providers and training centres. Private for-profit chains have grown rapidly in Indian cities. Aravind's advantages fall into four groups.
1. Scale and productivity. Aravind's volume and surgeon productivity give it a cost structure other providers find hard to match, and the volume itself raises quality by giving surgeons more practice.
2. Reputation. Five decades of equal-quality care, and a reputation strong enough that patients travel long distances to Madurai, sustain the paying volume on which the model depends.
3. Vertical integration. Aurolab gives Aravind secure, cheap supply of its most important consumables and a second business.
4. Outreach network. More than a hundred vision centres and thousands of annual camps give Aravind a patient-acquisition network in rural south India that would take years for another provider to replicate.
🏥
The Eye Care Landscape
Major Indian eye care providers and programmes
| Provider | Founded | Model | Relation to Aravind |
|---|---|---|---|
| Aravind Eye Care System | 1976, Madurai | Charitable, cross-subsidised, self-funding | Largest by volume |
| National Programme for Control of Blindness | 1976 | Government-funded programme | Partner and funder of camps |
| Sankara Nethralaya | 1978, Chennai | Charitable eye hospital and research centre | Peer institution |
| L V Prasad Eye Institute | 1987, Hyderabad | Charitable eye hospital, research and training | Peer institution |
| Private eye hospital chains | Various | For-profit, urban-focused | Competes for paying patients |
Where the moat is under pressure: Aravind's model depends on paying patients choosing it. The growth of private chains offering premium facilities in cities, and the rising expectations of India's middle class, compete directly for the patients who fund the free work. Aravind's other exposure is in staffing. Its productivity rests on surgeons willing to accept its pay and pace, and on young village women willing to train as MLOPs; both depend on labour-market conditions Aravind does not control.
The Flywheel
Aravind's model works as a self-reinforcing cycle in which volume, quality, reputation and surplus feed each other.
🔄
The Aravind Flywheel
How each link feeds the next
Step 1
Outreach creates volume. Camps and vision centres find patients who would otherwise never seek surgery and bring them to base hospitals.
Step 2
Volume lowers cost and raises quality. Assembly-line theatres and trained support staff let each surgeon perform thousands of operations a year, spreading fixed costs and building skill.
Step 3
Quality and price attract paying patients. Low complication rates and moderate fees bring paying patients through the paying-section doors.
Step 4
Paying patients fund free care and growth. Surpluses pay for the free hospitals, the outreach network and new facilities, which bring in more volume and restart the cycle.
Aurolab and LAICO sit alongside the flywheel, each strengthening it: Aurolab by lowering the cost of every operation, LAICO by spreading Aravind's reputation and methods and drawing trainees and partners into the network.
Growth Drivers and Strategic Outlook
1. Chronic eye disease. Diabetic retinopathy, glaucoma and age-related retinal disease are growing as India's population ages and diabetes spreads. Aravind's retina work, which in 2024-25 included 72,391 retinal laser procedures and 50,598 intravitreal injections, positions it for this shift, though these conditions require long-term follow-up rather than one-time surgery.
2. Primary care networks. The vision centre network, 117 strong by March 2025, is Aravind's main tool for extending reach at low cost, with teleconsultation linking rural patients to specialists.
3. New geographies. Chennai (2017) and Tirupati (2019) mark a willingness to build in larger cities and beyond Tamil Nadu.
4. Training and knowledge transfer. LAICO's consulting work and new facilities such as ARCORE extend Aravind's influence without requiring it to own hospitals elsewhere.
5. Aurolab's international business. Aurolab's relaunch as Aurolab 2.0 in 2024, noted in Aravind's activity report, signals continuing ambitions for the manufacturing arm in export markets.
Key Risks and Debates
1. Mission drift. Aravind's own leaders have named the risk that outreach and free care will be quietly deprioritised in favour of paying patients as the organisation grows.
2. Competition for paying patients. Private chains competing for affluent urban patients threaten the cross-subsidy that funds everything else.
3. Talent supply. The model depends on surgeons who accept high volume and moderate pay, and on a steady pipeline of MLOP recruits.
4. Changing case mix. As cataract backlogs shrink and chronic disease grows, the high-throughput, one-visit economics that made the model so efficient may become a smaller share of the work.
5. Succession and governance. Leadership remains concentrated in the founding family, which has provided continuity but narrows the pool from which future leaders are drawn.
Why Aravind Matters
Aravind matters because it overturns a widely held assumption: that serving the poor well requires either government money or charity, and that efficiency is the enemy of compassion. Its founders took the opposite view. They treated efficiency as the precondition for compassion at scale, and they built an organisation in which every operational improvement meant more free patients.
For operators, the lesson is about the relationship between mission and operations. Aravind's mission is simple and measurable, and its operating choices — volume, specialisation, self-selected pricing, vertical integration, outreach — all follow from it. When the mission is clear enough, it becomes a design specification.
Dr. V began with 11 beds and a phrase: eliminate needless blindness. Fifty years later, the organisation he started performs well over 700,000 procedures a year, half of them for patients who pay little or nothing, and still funds itself. It shows what a mission can do when it is backed by a production system built to deliver it.
